Marshall J. MD, Glesby; Donald R. Hoover, PhD
Unlike patients in a randomized, clinical trial, patients in an observational study choose if and when to begin treatment. Patients who live longer have more opportunities to select treatment; those who die earlier may be untreated by default. These facts are the essence of an often overlooked bias, termed “survivor treatment selection bias,” which can erroneously lead to the conclusion that an ineffective treatment prolongs survival. Unfortunately, misanalysis of survivor treatment selection bias has been prevalent in the recent literature on the acquired immunodeficiency syndrome. Approaches to mitigating this bias involve complex statistical models. At a minimum, initiation of therapy should be treated as a time-dependent covariate in a proportional hazards model. Investigators and readers should be on the alert for survivor treatment selection bias and should be cautious when interpreting the results of observational treatment studies.
Learn more about subscription options.
Register Now for a free account.
Glesby MJM, Hoover DR. Survivor Treatment Selection Bias in Observational Studies: Examples from the AIDS Literature. Ann Intern Med. 1996;124:999–1005. doi: 10.7326/0003-4819-124-11-199606010-00008
Download citation file:
Published: Ann Intern Med. 1996;124(11):999-1005.
HIV, Infectious Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only